Cannie, Douglas;
Patel, Kush;
Protonotarios, Alexandros;
Heenan, Imogen;
Bakalakos, Athanasios;
Syrris, Petros;
Menezes, Leon;
(2024)
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block.
Open Heart
, 11
(1)
, Article e002606. 10.1136/openhrt-2024-002606.
Preview |
PDF
e002606.full.pdf - Published Version Download (787kB) | Preview |
Abstract
OBJECTIVE: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiac disorder caused by deposition of wild type or mutated transthyretin. As ATTR-CM is associated with conduction disease, we sought to determine its prevalence in patients with idiopathic high-degree atrioventricular (AV) block requiring permanent pacemaker (PPM) implantation. METHODS: Consecutive patients aged 70-85 years undergoing PPM implantation for idiopathic high-degree AV block between November 2019 and November 2021 were offered a 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scan. Demographics, comorbidities, electrocardiographic and imaging data from the time of device implantation were retrospectively collected. RESULTS: 39 patients (79.5% male, mean (SD) age at device implantation 76.2 (2.9) years) had a DPD scan. 3/39 (7.7%, all male) had a result consistent with ATTR-CM (Perugini grade 2 or 3). Mean (SD) maximum wall thickness of those with a positive DPD scan was 19.0 mm (3.6 mm) vs 11.4 mm (2.7 mm) in those with a negative scan (p=0.06). All patients diagnosed with ATTR-CM had spinal canal stenosis and two had carpal tunnel syndrome. CONCLUSIONS: ATTR-CM should be considered in older patients requiring permanent pacing for high-degree AV block, particularly in the presence of left ventricular hypertrophy, carpal tunnel syndrome or spinal canal stenosis.
Type: | Article |
---|---|
Title: | Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1136/openhrt-2024-002606 |
Publisher version: | http://dx.doi.org/10.1136/openhrt-2024-002606 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | Bradycardia, Cardiomyopathy, Restrictive, Epidemiology, Pacemaker, Artificial |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10190237 |
Archive Staff Only
![]() |
View Item |